Viatris Inc. (VTRS)
Largest Insider Buys in Sector
VTRS Stock Price History Chart
VTRS Stock Performance
About Viatris Inc.
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It provides its medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as offers biosimilars franchises, including Fulphila, Ogivri, Hulio, and SEMGLEE. The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; Momenta Pharmaceuticals, Inc.; Theravance Biopharma, Inc.; Biocon Ltd.; and Fujifilm Kyowa Kirin Biologics Co. Ltd. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.
Insider Activity of Viatris Inc.
Over the last 12 months, insiders at Viatris Inc. have bought $0 and sold $8.69M worth of Viatris Inc. stock.
On average, over the past 5 years, insiders at Viatris Inc. have bought $1.09M and sold $5.66M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 100,704 shares for transaction amount of $993,546 was made by GOETTLER MICHAEL (Chief Executive Officer) on 2022‑03‑15.
List of Insider Buy and Sell Transactions, Viatris Inc.
| 2024-06-14 | Sale | Malik Rajiv | director | 264,300 0.0212% | $10.18 | $2.69M | +1.13% | |
| 2024-06-13 | Sale | Malik Rajiv | director | 85,660 0.0071% | $10.52 | $900,741 | -1.25% | |
| 2024-05-28 | Sale | Roman Brian | Chief Legal Officer | 89,419 0.0075% | $10.38 | $928,429 | +0.87% | |
| 2024-03-13 | Sale | Mauro Anthony | See Remarks | 250,000 0.0211% | $12.09 | $3.02M | -6.64% | |
| 2024-03-05 | Sale | Campbell Paul | See Remarks | 24,353 0.0021% | $12.33 | $300,272 | -7.57% | |
| 2024-03-05 | Sale | Lyons Dillon JoEllen | director | 20,000 0.0017% | $12.36 | $247,200 | -7.57% | |
| 2024-03-04 | Sale | Ni Xiangyang (Sean) | President, Greater China | 21,532 0.0018% | $12.51 | $269,314 | -8.09% | |
| 2024-02-23 | Sale | Cuneo Andrew | See Remarks | 4,000 0.0003% | $13.50 | $54,000 | -14.56% | |
| 2024-02-15 | Sale | Cuneo Andrew | See Remarks | 4,000 0.0003% | $12.50 | $50,000 | -9.75% | |
| 2024-01-04 | Sale | Cuneo Andrew | See Remarks | 4,000 0.0003% | $11.50 | $46,000 | +1.12% | |
| 2023-12-14 | Sale | Cuneo Andrew | See Remarks | 4,000 0.0003% | $10.50 | $42,000 | +11.90% | |
| 2023-11-24 | Sale | Ni Xiangyang (Sean) | President, Greater China | 14,937 0.0012% | $9.37 | $139,942 | +22.69% | |
| 2023-03-06 | Sale | Ni Xiangyang (Sean) | President, Greater China | 3,148 0.0003% | $11.08 | $34,891 | -7.29% | |
| 2023-03-03 | Sale | Ni Xiangyang (Sean) | President, Greater China | 3,093 0.0003% | $11.18 | $34,579 | -9.63% | |
| 2023-02-28 | Sale | Ni Xiangyang (Sean) | President, Greater China | 5,250 0.0004% | $11.22 | $58,893 | -11.72% | |
| 2022-11-25 | Sale | Ni Xiangyang (Sean) | President, Greater China | 12,800 0.001% | $10.95 | $140,220 | -9.06% | |
| 2022-08-17 | Sale | van der Meer Mohr Pauline | 18,880 0.0015% | $10.58 | $199,824 | -3.75% | ||
| 2022-05-27 | Sale | Taddese Menassie | See Remarks | 17,626 0.0014% | $12.07 | $212,811 | -16.13% | |
| 2022-03-15 | GOETTLER MICHAEL | Chief Executive Officer | 100,704 0.0082% | $9.87 | $993,546 | +8.94% | ||
| 2022-03-15 | CORNWELL W DON | 5,400 0.0004% | $9.90 | $53,443 | +8.94% |
Insider Historical Profitability
| Malik Rajiv | director | 645519 0.0542% | $10.43 | 0 | 2 | |
| Mauro Anthony | See Remarks | 243044 0.0205% | $10.43 | 0 | 1 | |
| Campbell Paul | See Remarks | 153826 0.013% | $10.43 | 0 | 1 | |
| Roman Brian | Chief Legal Officer | 67723 0.0057% | $10.43 | 0 | 1 | |
| Ni Xiangyang (Sean) | President, Greater China | 90804 0.0054% | $10.43 | 0 | 6 | |
| Lyons Dillon JoEllen | director | 58714 0.0049% | $10.43 | 0 | 1 | |
| Cuneo Andrew | See Remarks | 34795 0.0036% | $10.43 | 0 | 4 | |
| GOETTLER MICHAEL | Chief Executive Officer | 136796 0.0114% | $10.43 | 1 | 0 | +8.94% |
| KILTS JAMES M | director | 64905 0.0054% | $10.43 | 1 | 0 | <0.0001% |
| CORNWELL W DON | 22031 0.0018% | $10.43 | 4 | 0 | <0.0001% | |
| van der Meer Mohr Pauline | 20543 0.0017% | $10.43 | 0 | 1 | ||
| COURY ROBERT J | Executive Chairman | 0 0% | $10.43 | 0 | 2 | |
| Taddese Menassie | See Remarks | 0 0% | $10.43 | 0 | 1 |
Institutional Investor Ownership
| The Vanguard Group | $1.69B | 11.89 | 141.53M | -0.52% | -$8.82M | 0.03 | |
| BlackRock | $1.11B | 7.84 | 93.33M | +1.08% | +$11.88M | 0.03 | |
| State Street | $749.37M | 5.27 | 62.76M | +1.35% | +$10M | 0.03 | |
| T. Rowe Price | $691.14M | 4.86 | 57.88M | +17.02% | +$100.52M | 0.09 | |
| Davis Selected Advisers | $686.14M | 4.83 | 57.47M | -8.29% | -$62.04M | 3.92 | |
| Invesco | $373.05M | 2.62 | 31.24M | +3.65% | +$13.13M | 0.08 | |
| Geode Capital Management | $339.66M | 2.4 | 28.52M | +3.72% | +$12.19M | 0.03 | |
| Pacer Advisors Inc | $315.4M | 2.22 | 26.42M | +26.67% | +$66.41M | 0.8 | |
| Deerfield Management | $255.46M | 1.8 | 21.4M | +7.71% | +$18.29M | 4.94 | |
| Ameriprise Financial | $246.11M | 1.73 | 20.61M | -0.44% | -$1.08M | 0.07 | |
| Helm Capital Management LLC | $220.2M | 1.55 | 18.44M | +4.98% | +$10.44M | 6.51 | |
| Camber Capital Management Lp | $194.03M | 1.37 | 16.25M | -12.16% | -$26.86M | 6.84 | |
| Morgan Stanley | $171.4M | 1.21 | 14.35M | +8.47% | +$13.39M | 0.01 | |
| Dimensional Fund Advisors | $138.85M | 0.98 | 11.63M | -4.65% | -$6.78M | 0.04 | |
| BNY Mellon | $137.18M | 0.97 | 11.49M | -2.47% | -$3.48M | 0.03 | |
| Charles Schwab | $135.9M | 0.96 | 11.38M | +1.93% | +$2.58M | 0.03 | |
| Northern Trust | $131.31M | 0.92 | 11M | -2.59% | -$3.49M | 0.02 | |
| AustralianSuper | $129.45M | 0.91 | 10.84M | +0.45% | +$578,612.40 | 0.76 | |
| Slate Path Capital LP | $128.93M | 0.91 | 10.8M | -29.13% | -$52.99M | 2.57 | |
| Legal & General | $127.57M | 0.9 | 10.68M | -0.54% | -$688,997.16 | 0.03 | |
| LSV Asset Management | $117.06M | 0.82 | 9.8M | +4.27% | +$4.79M | 0.24 | |
| Schroder Investment Management Group | $109.56M | 0.77 | 9.18M | -11.62% | -$14.4M | 0.13 | |
| Amundi | $103.89M | 0.75 | 8.88M | +22.62% | +$19.16M | 0.04 | |
| JPMorgan Chase | $102.57M | 0.72 | 8.59M | +88.48% | +$48.15M | 0.01 | |
| Bank of America | $87.29M | 0.61 | 7.31M | +14.03% | +$10.74M | 0.01 | |
| Deutsche Bank | $81.79M | 0.58 | 6.85M | -28.87% | -$33.2M | 0.04 | |
| Icici Prudential Asset Management Co Ltd | $73.42M | 0.52 | 6.15M | -26% | -$25.8M | 8.32 | |
| Glenview Capital Management | $61.4M | 0.43 | 5.14M | -15.22% | -$11.02M | 1.2 | |
| Ubs Asset Management Americas Inc | $59.46M | 0.42 | 4.98M | +6.25% | +$3.5M | 0.02 | |
| AQR Capital | $58.77M | 0.42 | 4.95M | -44.73% | -$47.57M | 0.1 | |
| Fil Ltd | $50.76M | 0.36 | 4.25M | +28.24% | +$11.18M | 0.05 | |
| Nordea Investment Management Ab | $47.58M | 0.34 | 4.02M | -8.28% | -$4.3M | 0.06 | |
| Brandywine Global Investment Management | $47.98M | 0.34 | 4.02M | +13.09% | +$5.55M | 0.35 | |
| Invenomic Capital Management LP | $47.19M | 0.33 | 3.95M | -32.01% | -$22.22M | 2.54 | |
| TSW (Thompson, Siegel & Walmsley LLC) | $44.79M | 0.32 | 3.75M | +77,582.09% | +$44.73M | 0.7 | |
| Swiss National Bank | $42.9M | 0.3 | 3.59M | -4.22% | -$1.89M | 0.03 | |
| Fidelity Investments | $42.47M | 0.3 | 3.56M | -16.78% | -$8.57M | <0.01 | |
| National Pension Service | $42.26M | 0.3 | 3.54M | +152.08% | +$25.49M | 0.05 | |
| Grantham Mayo Van Otterloo & Co LLC | $42.24M | 0.3 | 3.54M | -14.81% | -$7.34M | 0.15 | |
| Barclays | $39.02M | 0.27 | 3.27M | +5.28% | +$1.96M | 0.02 | |
| Goldman Sachs | $37M | 0.26 | 3.1M | -25.35% | -$12.56M | 0.01 | |
| First Trust | $36.85M | 0.26 | 3.09M | -6.87% | -$2.72M | 0.04 | |
| Wells Fargo | $36.42M | 0.26 | 3.05M | +5.07% | +$1.76M | 0.01 | |
| Nuveen | $36.25M | 0.26 | 3.04M | -0.07% | -$24,405.36 | 0.01 | |
| HSBC | $35.89M | 0.25 | 3.01M | +26.3% | +$7.47M | 0.03 | |
| Sumitomo Mitsui Trust Holdings | $33.92M | 0.24 | 2.84M | +0.54% | +$183,541.68 | 0.02 | |
| Russell Investments Group Ltd | $33.35M | 0.24 | 2.79M | +33.98% | +$8.46M | 0.05 | |
| CalPERS | $27.95M | 0.2 | 2.34M | -1.47% | -$417,386.58 | 0.02 | |
| Callodine Capital Management | $27.46M | 0.19 | 2.3M | -8.73% | -$2.63M | 6.67 | |
| Allspring Global Investments | $26.83M | 0.19 | 2.25M | -30.02% | -$11.51M | 0.04 |